Sennheiser sells its consumer electronics division to Sonova, a Swiss company best known for its medical audio products like hearing aids and cochlear implants
From blasting your eardrums to assisting them in later life — Sonova, a Swiss company best known for its medical audio products …
Context & Ripple Effects
Sonova’s purchase brings a consumer-audio business into a company identified here with hearing aids and cochlear implants. It follows adjacent consolidation by GN Group, whose acquisition of a videoconferencing technology provider paired connected hearing aids with communications technology.
First-order effects
- Sonova takes control of Sennheiser’s consumer electronics division, extending its product footprint from medical audio into consumer listening devices.
- Sennheiser transfers its consumer-electronics operation to Sonova, changing the owner responsible for those products and their commercial strategy.
Second-order effects
- GN Group faces a larger hearing-audio rival with a consumer electronics business, strengthening the competitive overlap between connected hearing products and mainstream personal audio.
- Consumer-audio competitors such as Sonos must contend with a new owner whose existing expertise is centered on hearing-related audio products.
Third-order effects
- The deal and GN Group’s earlier communications acquisition point toward a more integrated audio market, where hearing technology, consumer devices, and communications products are increasingly assembled under the same corporate portfolios.
The trend: Audio companies are converging consumer listening, connected hearing, and communications technologies through acquisitions and portfolio expansion.